MED19, mediator complex subunit 19, 219541

N. diseases: 50; N. variants: 0
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0699885
Disease: Carcinoma of bladder
Carcinoma of bladder
0.030 Biomarker disease BEFREE Our data suggest that Med19 expression correlates with aggressive characteristics of BCa and Med19 knockdown suppresses the proliferation and migration of BCa cells through down-regulating the Wnt/β-catenin pathway, thereby highlighting Med19 as a potential therapeutic target for BCa treatment. 28631286 2017
CUI: C0699885
Disease: Carcinoma of bladder
Carcinoma of bladder
0.030 Biomarker disease BEFREE The influence of Med19 on the proliferation of bladder cancer cells were assessed using MTT, BrdU, colony formation and tumorigenicity experiments. 21478038 2013
CUI: C0699885
Disease: Carcinoma of bladder
Carcinoma of bladder
0.030 Biomarker disease BEFREE Fifty-two BCa samples were included for immunohistochemical staining of Med19 and BMP-2. 23276457 2013